Genmab A/S (GMAB)

Growth

Revenue 5Y33.63%
Revenue 3Y37.81%
EPS 5Y18.25%
EPS 3Y24.02%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC16.25%
ROE23.55%
ROA18.43%
ROTA18.43%

Capital Structure

Market Cap25.68B
EV15.93B
Cash10.38B
Current Ratio9.62
Debt/Equity0.13
Net Debt/EBITDA-1.29
Show More

Income Statement

Select a metric from the list below to chart it

Dec '02
Dec '06
Dec '10
Dec '14
Dec '18
TTM
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
97.0
124.3
165.6
265.4
345.6
442.0
784.1
1,477.5
1,239.4
1,751.6
Revenue % Chg.
36.9%
28.2%
33.2%
60.3%
30.2%
27.9%
77.4%
88.4%
-16.1%
51.6%
R&D Expenses
77.1
73.9
71.3
96.6
127.8
209.1
348.7
458.4
610.9
762.6
R&D Expenses % Chg.
-1.7%
-4.2%
-3.6%
35.5%
32.3%
63.7%
66.7%
31.5%
33.3%
37.0%
Selling, General, & Admin Expenses
9.8
11.6
13.3
15.0
21.5
31.2
50.0
96.6
187.5
331.3
Selling, General, & Admin Expenses % Chg.
3.3%
19.2%
14.7%
12.3%
43.5%
45.4%
60.0%
93.3%
94.1%
126.2%
Other Expenses
-
-
-25.7
-
-
-
-
-
-
-
Operating Income
10.1
38.7
106.7
153.8
196.4
201.7
385.5
922.5
441.0
657.7
Operating Income % Chg.
-
282.9%
175.4%
44.1%
27.7%
2.7%
91.1%
139.3%
-52.2%
45.4%
Operating Income Margin
10.4%
31.2%
64.5%
58.0%
56.8%
45.6%
49.2%
62.4%
35.6%
37.5%
Operating Income Margin % Chg.
-
198.8%
106.7%
-10.1%
-2.0%
-19.7%
7.7%
27.0%
-43.0%
-4.1%
Total Other Income/Expenses Net
-0.6
4.7
4.0
11.3
-41.0
33.9
32.3
-59.8
141.0
414.7
Total Other Income/Expenses Net % Chg.
-
-
-15.6%
185.0%
-
-
-4.6%
-
-
501.3%
Income Before Tax
9.6
43.4
110.7
165.2
155.4
235.5
417.8
862.7
582.0
1,072.4
Income Before Tax % Chg.
-
354.6%
154.8%
49.2%
-5.9%
51.5%
77.4%
106.5%
-32.5%
105.7%
Income Before Tax Margin
9.9%
35.0%
66.9%
62.2%
45.0%
53.3%
53.3%
58.4%
47.0%
61.2%
Income Before Tax Margin % Chg.
-
254.8%
91.2%
-6.9%
-27.7%
18.5%
-0.0%
9.6%
-19.6%
35.7%
Income Tax Expense
-0.7
-0.6
-0.9
-8.3
-5.8
20.4
101.3
167.5
142.5
246.2
Income Tax Expense % Chg.
80.5%
16.9%
51.5%
849.8%
29.9%
-
395.6%
65.4%
-14.9%
142.4%
Net Income
16.4
44.0
111.6
173.5
161.3
215.1
316.5
695.3
439.5
826.2
Net Income % Chg.
-
168.1%
153.4%
55.5%
-7.0%
33.4%
47.1%
119.7%
-36.8%
96.8%
Net Income Margin
16.9%
35.4%
67.4%
65.4%
46.7%
48.7%
40.4%
47.1%
35.5%
47.2%
Net Income Margin % Chg.
-
109.2%
90.2%
-3.0%
-28.6%
4.3%
-17.1%
16.6%
-24.6%
29.8%
Weighted Avg. Shares Out
509.8
563.2
585.2
598.8
608.3
612.7
629.6
651.8
656.3
654.2
Weighted Avg. Shares Out % Chg.
10.7%
10.5%
3.9%
2.3%
1.6%
0.7%
2.8%
3.5%
0.7%
0.1%
EPS
0.0
0.1
0.2
0.3
0.3
0.4
0.5
1.1
0.7
1.3
EPS % Chg.
-
143.2%
143.9%
52.0%
-8.5%
32.5%
43.2%
112.2%
-37.0%
96.7%
Weighted Avg. Shares Out Dil
519.1
572.5
607.7
617.7
620.9
620.5
636.4
658.9
660.5
658.1
Weighted Avg. Shares Out Dil % Chg.
12.7%
10.3%
6.2%
1.6%
0.5%
-0.1%
2.6%
3.5%
0.2%
0.0%
EPS Diluted
0.0
0.1
0.2
0.3
0.3
0.3
0.5
1.1
0.7
1.3
EPS Diluted % Chg.
-
143.5%
138.8%
53.0%
-7.5%
33.5%
43.4%
112.2%
-36.9%
96.7%
Interest Income
4.2
5.6
5.4
4.8
6.1
9.2
50.9
26.9
28.8
235.3
Interest Income % Chg.
60.5%
34.0%
-2.8%
-12.6%
27.1%
51.9%
453.1%
-47.1%
7.1%
681.6%
Interest Expense
0.5
0.6
0.0
0.0
0.4
0.1
2.0
1.5
1.9
31.1
Interest Expense % Chg.
22.2%
21.9%
-97.1%
80.5%
1215.5%
-85.1%
3257.3%
-28.6%
30.0%
-
EBIT
13.3
48.5
116.1
169.9
161.1
244.7
466.6
888.1
608.9
1,276.5
EBIT % Chg.
-
265.7%
139.6%
46.3%
-5.2%
51.9%
90.7%
90.4%
-31.4%
130.5%
EBIT Margin
13.7%
39.0%
70.1%
64.0%
46.6%
55.4%
59.5%
60.1%
49.1%
72.9%
EBIT Margin % Chg.
-
185.3%
79.9%
-8.7%
-27.2%
18.8%
7.5%
1.0%
-18.3%
52.0%
Depreciation & Amortization
1.7
1.8
4.6
6.0
10.2
12.8
20.3
37.8
36.2
-
Depreciation & Amortization % Chg.
-22.8%
5.7%
158.1%
28.7%
70.3%
25.6%
58.7%
86.3%
-4.2%
-
EBITDA
15.0
50.3
120.8
175.9
171.3
257.5
486.9
926.0
645.1
1,276.5
EBITDA % Chg.
-
236.0%
140.3%
45.6%
-2.6%
50.3%
89.1%
90.2%
-30.3%
130.5%
EBITDA Margin
15.4%
40.4%
72.9%
66.3%
49.6%
58.2%
62.1%
62.7%
52.1%
72.9%
EBITDA Margin % Chg.
-
162.2%
80.3%
-9.2%
-25.2%
17.6%
6.6%
0.9%
-16.9%
52.0%